Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

Mammen P. Mammen; Pablo Tebas; Joseph Agnes; Mary Giffear; Kimberly A. Kraynyak; Elliott Blackwood; Dinah Amante; Emma L. Reuschel; Mansi Purwar; Aaron Christensen-Quick; Nieman Liu; Viviane M. Andrade; Julie Carter; Gabriella Garufi; Malissa C. Diehl; Albert Sylvester; Matthew P. Morrow; Patrick Pezzoli; Abhijeet J. Kulkarni; Faraz I. Zaidi; Drew Frase; Kevin Liaw; Hedieh Badie; Keiko O. Simon; Trevor R.F. Smith; Stephanie Ramos; Robert Spitz; Robert J. Juba; Jessica Lee; Michael Dallas; Ami Shah Brown; Jacqueline E. Shea; J. Joseph Kim; David B. Weiner; Kate E. Broderick; Jean D. Boyer; Laurent M. Humeau

bioRxiv (2021) - Comments
doi: 10.1101/2021.05.07.21256652

Mammen P. Mammen, Pablo Tebas, Joseph Agnes, Mary Giffear, Kimberly A. Kraynyak, Elliott Blackwood, Dinah Amante, Emma L. Reuschel, Mansi Purwar, Aaron Christensen-Quick, Nieman Liu, Viviane M. Andrade, Julie Carter, Gabriella Garufi, Malissa C. Diehl, Albert Sylvester, Matthew P. Morrow, Patrick Pezzoli, Abhijeet J. Kulkarni, Faraz I. Zaidi